Clinical Trial Update: Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

View source ↗

Summary

This clinical trial update describes RTGene 2, a study on transcriptional responses as indicators of individualized radiation effects in cancer; the trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Cancer | Status: ACTIVE_NOT_RECRUITING